Read + Share
Okada T, Matsuki T, Fushimi C, Okamoto I, et al. Nivolumab for Platinum-refractory and -sensitive Recurrent and Metastatic Head
and Neck Squamous Cell Carcinoma. Anticancer Res 2022;42:4907-4912.
PMID: 36192003
|
 |
|
Okada T, Matsuki T, Fushimi C, Okamoto I, et al. Nivolumab for Platinum-refractory and -sensitive Recurrent and Metastatic Head
and Neck Squamous Cell Carcinoma. Anticancer Res 2022;42:4907-4912.
PMID: 36192003
|
|
|
|